Izokibep was effective in reducing disease activity among patients with HS, including those who switched to izokibep from ...

Three controlled trials evaluating different investigational treatments for hidradenitis suppurativa identify new targets capable of interrupting disease pathophysiology.

Please provide your email address to receive an email when new articles are posted on . Patients treated by dermatologists vs. non-dermatologists were much more likely to be prescribed biologics (19.7 ...

Hidradenitis suppurativa is one of dermatology’s most punishing diseases. Chronic, inflammatory, and often excruciatingly ...

Whether you’re newly diagnosed or unhappy with your current hidradenitis suppurativa treatment, a dermatologist who listens is key to getting the care you need. People with HS might not get a ...

Hidradenitis suppurativa (HS) is one of dermatology’s most burdensome chronic inflammatory diseases, and a new research letter published in the Archives of Dermatological Research suggests that one o ...

Please provide your email address to receive an email when new articles are posted on . To control hidradenitis suppurativa, dermatologists often need to combine medical interventions with surgery.

There’s an added layer of complexity if you’re a person of color. Black women, in particular, have a higher risk of HS. While anyone can develop darker areas after their skin is damaged or ...

For many people living with hidradenitis suppurativa (HS), flares can feel sudden and unpredictable-appearing without warning and, often, without a clear reason why. But dermatologists say that while ...

Merck (NYSE:MRK) reported positive Phase 2b results for tulisokibart in moderate to severe hidradenitis suppurativa on 1 ...

Day 2 of EADV 2026 highlighted new findings involving GLP-1–associated nail changes, long-term atopic dermatitis control, emerging therapies, alopecia, and hidradenitis suppurativa. The second day of ...